Skip to main content
Log in

Effect of plasma protein and tissue binding on the time course of drug concentration in plasma

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

We have studied by digital computer simulation the effect of concentration-dependent plasma protein and tissue binding on the time course of drug concentrations (both unbound and total) in plasma following rapid injection of a drug whose elimination rate is proportional to either free or total drug concentration in plasma, assuming instantaneous equilibration of the drug between vascular and nonvascular spaces. The following observations were made when elimination rate was assumed to be a function of free drug concentration: (a) when plasma protein binding is nonlinear and there is either no tissue binding or linear tissue binding, log concentration-time plots of free drug are always concave whereas such plots for total (sum of free and bound) drug can be convex, almost linear, or concave (apparently biexponential) depending on the plasma protein binding parameters relative to the initial concentration; (b) linear tissue binding in association with nonlinear plasma protein binding can reduce the concavity or enhance the convexity of log total concentration-time plots. When drug elimination rate was assumed to be a function of total concentration in plasma, nonlinear plasma protein binding in association with linear or no tissue binding yielded convex log total concentration-time plots which could sometimes be described by Michaelis-Menten kinetics. In general, drug concentration-dependent changes in the apparent volume of distribution resulting from nonlinear plasma protein and (where applicable) tissue binding have a pronounced effect on the slope of log total plasma concentration- time plots. It appears that under clinically realistic conditions an otherwise marked curvature of such plots, due to nonlinear plasma protein binding, may in fact be dampened or overcome by linear tissue binding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. G. Levy and A. Yacobi. Effect of plasma protein binding on elimination of warfarin.J. Pharm. Sci. 63:805–806 (1974).

    Article  CAS  PubMed  Google Scholar 

  2. G. R. Wilkinson and D. G. Shand. A physiologic approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).

    CAS  PubMed  Google Scholar 

  3. M. Gibaldi and P. J. McNamara. Apparent volumes of distribution and drug binding to plasma proteins and tissues.Eur. J. Clin. Pharmacol. 13:373–378 (1978).

    Article  CAS  PubMed  Google Scholar 

  4. M. Gibaldi, G. Levy, and P. J. McNamara. Effect of plasma protein and tissue binding on the biologic half-life of drugs.Clin. Pharmacol. Ther. 24:1–4 (1978).

    CAS  PubMed  Google Scholar 

  5. E. Krüger-Thiemer, W. Diller, and P. Bünger. Pharmacokinetic models regarding protein binding of drugs.Antimicrob. Agents Chemother. 5:183–191 (1965).

    PubMed  Google Scholar 

  6. J. J. Coffey, F. J. Bullock, and P. T. Schoenemann. Numerical solution of nonlinear pharmacokinetic equations: Effects of plasma protein binding on drug distribution and elimination.J. Pharm. Sci. 60:1623–1628 (1971).

    Article  CAS  PubMed  Google Scholar 

  7. B. K. Martin. Kinetics of elimination of drugs possessing high affinity for the plasma proteins.Nature 207:959–960 (1965).

    Article  CAS  PubMed  Google Scholar 

  8. J. G. Wagner.Fundamentals of Clinical Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill., 1971, pp. 270–283.

    Google Scholar 

  9. Control Data Corp.,MIMIC, Publication No. 44610400, St. Paul, Minn., 1968.

  10. L. B. Sheiner and T. N. Tozer.Clinical Pharmacology: Basic Principles in Therapeutics, 2nd ed., Macmillan, New York, 1978, pp. 71–109.

    Google Scholar 

  11. W. M. Wardell. Drug displacement from protein binding. Source of sulphadoxine liberated by phenylbutazone.Br. J. Pharmacol. 43:325–334 (1971).

    CAS  PubMed Central  PubMed  Google Scholar 

  12. E. JÄhnchen, L. B. Wingard, Jr., and G. Levy. Effect of phenylbutazone on the distribution, elimination and anticoagulant action of dicumarol in rats.J. Pharmacol. Exp. Ther. 187:176–184 (1973).

    PubMed  Google Scholar 

  13. C.-M. Lai and G. Levy. Comparative pharmacokinetics of coumarin anticoagulants. XXXVII. Simultaneousin vivo displacement of dicumarol from serum protein and tissue binding sites by tolbutamide in rats.J. Pharm. Sci. (in press).

  14. D. Shen and M. Gibaldi. Critical evaluation of use of effective protein fractions in developing pharmacokinetic models for drug distribution.J. Pharm. Sci. 63: 1698–1703 (1974).

    Article  CAS  PubMed  Google Scholar 

  15. G. Levy, C.-M. Lai, and A. Yacobi. Comparative pharmacokinetics of coumarin anticoagulants. XXXII. Interindividual differences in binding of warfarin and dicumarol in rat liver and implications for physiological pharmacokinetic modeling.J. Pharm. Sci. 67:229–231 (1978).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by Grant GM-20852 from the National Institute of General Medical Sciences, National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McNamara, P.J., Levy, G. & Gibaldi, M. Effect of plasma protein and tissue binding on the time course of drug concentration in plasma. Journal of Pharmacokinetics and Biopharmaceutics 7, 195–206 (1979). https://doi.org/10.1007/BF01059738

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01059738

Key words

Navigation